tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Haemonetics price target lowered to $70 from $90 at Mizuho

Mizuho lowered the firm’s price target on Haemonetics (HAE) to $70 from $90 and keeps an Outperform rating on the shares. The firm says a rebound in Vascade MVP is expected to take at least six months.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1